For example, in vitro experiments showed 40μM EGCG reduced PKM2 levels in pancreatic cancer cells by 34% to 49%, and in vivo experiments demonstrated PKM2 levels were significantly decreased in murine pancreatic tumor xenografts (187). This evidence concerns the gene PKM and familial pancreatic carcinoma.